(Q54535390)

31 May 2018

title

Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. (English)

1 reference

31 May 2018

0 references

T Adachi

1

1 reference

31 May 2018

S Motojima

2

1 reference

31 May 2018

A Hirata

3

1 reference

31 May 2018

T Fukuda

4

1 reference

31 May 2018

N Kihara

5

1 reference

31 May 2018

A Kosaku

6

1 reference

31 May 2018

H Ohtake

7

1 reference

31 May 2018

S Makino

8

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 December 1996

1 reference

31 May 2018

The Journal of Allergy and Clinical Immunology

published in

1 reference

31 May 2018

volume

98

1 reference

31 May 2018

issue

6 Pt 2

1 reference

31 May 2018

page(s)

S207-15

1 reference

31 May 2018

The eosinophil and bronchial asthma: current understanding

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

The effects of glucocorticoids on human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Theophylline--an immunomodulatory role in asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Cell death: the significance of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. Involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Dose- and time-related effect of troleandomycin on methylprednisolone elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

Inhibition of theophylline clearance by troleandomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2896%2970068-4

7 January 2021

10.1016/S0091-6749(96)70068-4

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018